Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants
Journal of Drugs in Dermatology · 01.01.2026 · 25 (1) · 67-74
DOI: 10.36849/jdd.9384 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.12.2025. Verfasst von Shari R Lipner und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antifungal Agents, Foot Dermatoses, Onychomycosis, Triazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Lipner, S. R., Gupta, A. K., Vlahovic, T. C., Rosen, T., Elewski, B., Choi, S. Y., Guenin, E., & Gold, L. S. (2026). Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants. Journal of Drugs in Dermatology, 25(1), 67-74. https://doi.org/10.36849/jdd.9384
Vancouver
Lipner SR, Gupta AK, Vlahovic TC, Rosen T, Elewski B, Choi SY, et al. Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants. Journal of Drugs in Dermatology. 2026;25(1):67-74. doi:10.36849/jdd.9384
BibTeX
@article{Lipner2026,
author = {Lipner, Shari R and Gupta, Aditya K and Vlahovic, Tracey C and Rosen, Ted and Elewski, Boni and Choi, Su Yong and Guenin, Eric and Gold, Linda Stein},
title = {Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {1},
pages = {67--74},
doi = {10.36849/jdd.9384}
}
EUVIMED